Zimmer Holdings has received FDA clearance for the TM-S Trabecular Metal Cervical Interbody Fusion Device with porous metal technology in the US for use with supplemental fixation systems and with autogenous bone graft.

The device is designed to treat the cervical spine of patients with degenerative disc disease with or without radicular symptoms at one level from C2-T1.

Trabecular Metal Material provides an osteoconductive scaffold which supports bony in-growth and vascularization into the implant.

The TM-S system is constructed from Zimmer‘s proprietary Trabecular Metal Technology, a porous metal biomaterial with structural and mechanical properties similar to cancellous bone.